RBQM plays an important part in the way clinical trials are run today. It is at the core of everything from design to execution and conclusion.
This comes at a time when Clinical Data Management (CDM) is under increasing pressure from the five Vs – variety, volume, velocity, veracity and value.
We are seeing more and more systems being responsible for collecting data. Many of those data sources can also capture much more data, much faster, than we have been used to in the past.
As data managers, we are responsible for ensuring the veracity and value of that data is maintained. So how do we continue to deliver quality results under these pressures?
A risk-based approach can help us scale to meet these demands, move away from a one-size-fits-all approach and become more targeted and efficient.